Pfizer and AstraZeneca have been struggling to keep up with global demand for COVID-19 vaccines, creating shortages and delays in vaccine programs in developing nations.
As CGTN’s Franc Contreras reports, Mexico is one such case.
Check out The China Report, our new weekly newsletter. Subscribe here!
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3